The administration of HCD in piglets has been associated with hepatic steatosis, insulin resistance, and hepatic inflammation, including increased myeloperoxidase activity and expression of proinflammatory cytokines and chemokines, particularly IL-2, CXCL2, TNFα, and IL-6. The gene discussed is CXCL2; the disease is fatty liver disease.